Table of Content




1 EXECUTIVE SUMMARY


2 MARKET INTRODUCTION

2.1 SCOPE OF THE STUDY

2.2 RESEARCH OBJECTIVE

2.3 LIST OF ASSUMPTIONS & LIMITATIONS


3 RESEARCH METHODOLOGY

3.1 DATA MINING

3.2 SECONDARY RESEARCH

3.3 PRIMARY RESEARCH

3.3.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS

3.3.2 BREAKDOWN OF PRIMARY RESPONDENTS

3.4 FORECASTING TECHNIQUES

3.5 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION

3.5.1 BOTTOM-UP APPROACH

3.5.2 TOP-DOWN APPROACH

3.6 DATA TRIANGULATION

3.7 VALIDATION


4 MARKET DYNAMICS

4.1 OVERVIEW

4.2 DRIVERS

4.2.1 INCREASING NUMBER OF PATIENTS SUFFERING FROM ACUTE SINUSITIS

4.2.2 AVAILABILITY OF SEVERAL TREATMENT AND DIAGNOSTIC OPTIONS

4.3 RESTRAINTS

4.3.1 LACK OF AWARENESS RELATED TO ACUTE SINUSITIS

4.4 OPPORTUNITIES

4.4.1 RISING GLOBAL R&D INITIATIVES AND HEALTHCARE EXPENDITURE


5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS

5.1.1 R&D

5.1.2 MANUFACTURING

5.1.3 DISTRIBUTION & SALES

5.1.4 POST-SALES MONITORING

5.2 PORTER’S FIVE FORCES MODEL

5.2.1 THREAT OF NEW ENTRANTS

5.2.2 BARGAINING POWER OF SUPPLIERS

5.2.3 THREAT OF SUBSTITUTES

5.2.4 BARGAINING POWER OF BUYERS

5.2.5 INTENSITY OF RIVALRY

5.3 IMPACT OF COVID-19 ON THE GLOBAL ACUTE SINUSITIS MARKET

5.3.1 IMPACT ON SUPPLY CHAIN

5.3.2 IMPACT ON PATIENTS SUFFERING FROM ACUTE SINUSITIS

5.3.3 IMPACT ON DEMAND AND SUPPLY

5.3.4 IMPACT ON TECHNOLOGY


6 GLOBAL ACUTE SINUSITIS MARKET, BY DIAGNOSIS &TREATMENT

6.1 INTRODUCTION

6.2 BY DIAGNOSIS

6.2.1 NASAL ENDOSCOPY

6.2.2 IMAGING TEST

6.2.3 LABORATORY TEST

6.2.4 ALLERGY TESTING

6.3 BY TREATMENT

6.3.1 SALINE NASAL SPRAY

6.3.2 NASAL CORTICOSTEROIDS

6.3.3 DECONGESTANTS

6.3.4 OTC PAIN RELIEVERS

6.3.5 ALLERGY SHOTS

6.3.6 ANTIBIOTICS


7 GLOBAL ACUTE SINUSITIS MARKET, BY END USER

7.1 INTRODUCTION

7.2 HOSPITALS & CLINICS

7.3 RESEARCH CENTERS

7.4 OTHERS


8 GLOBAL ACUTE SINUSITIS MARKET, BY REGION

8.1 OVERVIEW

8.2 AMERICAS

8.2.1 NORTH AMERICA

8.2.1.1 US

8.2.1.2 CANADA

8.2.2 SOUTH AMERICA

8.3 EUROPE

8.3.1 WESTERN EUROPE

8.3.1.1 GERMANY

8.3.1.2 FRANCE

8.3.1.3 UK

8.3.1.4 ITALY

8.3.1.5 SPAIN

8.3.1.6 REST OF WESTERN EUROPE

8.3.2 EASTERN EUROPE

8.4 ASIA-PACIFIC

8.4.1 CHINA

8.4.2 INDIA

8.4.3 JAPAN

8.4.4 REPUBLIC OF KOREA

8.4.5 AUSTRALIA

8.4.6 REST OF ASIA PACIFIC

8.5 MIDDLE EAST & AFRICA

8.5.1 SAUDI ARABIA

8.5.2 UNITED ARAB EMIRATES

8.5.3 OMAN

8.5.4 KUWAIT

8.5.5 QATAR

8.5.6 REST OF THE MIDDLE EAST & AFRICA


9 COMPETITIVE LANDSCAPE

9.1 OVERVIEW

9.2 COMPETITIVE BENCHMARKING

9.3 MAJOR GROWTH STRATEGY IN THE GLOBAL ACUTE SINUSITIS MARKET

9.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL ACUTE SINUSITIS MARKET

9.5 KEY DEVELOPMENT ANALYSIS

9.6 KEY DEVELOPMENTS & GROWTH STRATEGIES

9.6.1 PRODUCT LAUNCHES/PRODUCT APPROVALS

9.6.2 MERGERS & ACQUISITIONS

9.7 FINANCIAL MATRIX

9.7.1 SALES (USD MILLION), 2020

9.7.2 RESEARCH & DEVELOPMENT EXPENDITURE (USD MILLION), 2020


10 COMPANY PROFILES

10.1 SANOFI

10.1.1 COMPANY OVERVIEW

10.1.2 FINANCIAL OVERVIEW

10.1.3 PRODUCTS/SERVICES OFFERED

10.1.4 KEY DEVELOPMENTS

10.1.5 SWOT ANALYSIS

10.1.6 KEY STRATEGIES

10.2 ABBOTT

10.2.1 COMPANY OVERVIEW

10.2.2 FINANCIAL OVERVIEW

10.2.3 PRODUCTS/SERVICES OFFERED

10.2.4 KEY DEVELOPMENTS

10.2.5 SWOT ANALYSIS

10.2.6 KEY STRATEGIES

10.3 BAYER AG

10.3.1 COMPANY OVERVIEWS

10.3.2 FINANCIAL OVERVIEW

10.3.3 PRODUCTS/SERVICES OFFERED

10.3.4 KEY DEVELOPMENTS

10.3.5 SWOT ANALYSIS

10.3.6 KEY STRATEGIES

10.4 AUROBINDO PHARMA

10.4.1 COMPANY OVERVIEW

10.4.2 FINANCIAL OVERVIEW

10.4.3 PRODUCTS/SERVICES OFFERED

10.4.4 KEY DEVELOPMENTS

10.4.5 SWOT ANALYSIS

10.4.6 KEY STRATEGIES

10.5 BRISTOL-MYERS SQUIBB

10.5.1 COMPANY OVERVIEW

10.5.2 FINANCIAL OVERVIEW

10.5.3 PRODUCTS/SERVICES OFFERED

10.5.4 KEY DEVELOPMENTS

10.5.5 SWOT ANALYSIS

10.5.6 KEY STRATEGIES

10.6 MERCK KGAA

10.6.1 COMPANY OVERVIEW

10.6.2 FINANCIAL OVERVIEW

10.6.3 PRODUCTS OFFERED

10.6.4 KEY DEVELOPMENTS

10.6.5 SWOT ANALYSIS

10.6.6 KEY STRATEGIES

10.7 ASTRAZENECA

10.7.1 COMPANY OVERVIEW

10.7.2 FINANCIAL OVERVIEW

10.7.3 PRODUCTS/SERVICES OFFERED

10.7.4 KEY DEVELOPMENTS

10.7.5 SWOT ANALYSIS

10.7.6 KEY STRATEGIES

10.8 DR. REDDY’S LABORATORIES LTD

10.8.1 COMPANY OVERVIEW

10.8.2 FINANCIAL OVERVIEW

10.8.3 PRODUCTS/SERVICES OFFERED

10.8.4 KEY DEVELOPMENTS

10.8.5 SWOT ANALYSIS

10.8.6 KEY STRATEGIES

10.9 NOVARTIS AG

10.9.1 COMPANY OVERVIEW

10.9.2 FINANCIAL OVERVIEW

10.9.3 PRODUCTS OFFERED

10.9.4 KEY DEVELOPMENTS

10.9.5 SWOT ANALYSIS

10.9.6 KEY STRATEGIES

10.10 GLAXOSMITHKLINE PLC

10.10.1 COMPANY OVERVIEW

10.10.2 FINANCIAL OVERVIEW

10.10.3 PRODUCTS/SERVICES OFFERED

10.10.4 KEY DEVELOPMENTS

10.10.5 SWOT ANALYSIS

10.10.6 KEY STRATEGIES

11 APPENDIX

11.1 REFERENCES

11.2 RELATED REPORTS

?



List of Figures

LIST OF FIGURES

FIGURE 1 MARKET SYNOPSIS

FIGURE 2 GLOBAL ACUTE SINUSITIS MARKET STRUCTURE

FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES

FIGURE 4 MARKET DYNAMICS: GLOBAL ACUTE SINUSITIS MARKET

FIGURE 5 DRIVERS IMPACT ANALYSIS

FIGURE 6 RESTRAINTS IMPACT ANALYSIS

FIGURE 7 VALUE CHAIN ANALYSIS: GLOBAL ACUTE SINUSITIS MARKET

FIGURE 8 PORTER’S FIVE FORCES ANALYSIS: GLOBAL ACUTE SINUSITIS MARKET

FIGURE 9 GLOBAL: ACUTE SINUSITIS MARKET, BY DIAGNOSIS & TREATMENT, 2020 & 2027 (USD MILLION)

FIGURE 10 GLOBAL: ACUTE SINUSITIS MARKET, BY DIAGNOSIS, 2020 & 2027 (USD MILLION)

FIGURE 11 GLOBAL: ACUTE SINUSITIS MARKET, BY TREATMENT, 2020 & 2027 (USD MILLION)

FIGURE 12 GLOBAL: ACUTE SINUSITIS MARKET, BY END USER, 2020 & 2027 (USD MILLION)

FIGURE 13 GLOBAL: ACUTE SINUSITIS MARKET, BY REGION 2020 & 2027 (USD MILLION)

FIGURE 14 GLOBAL: ACUTE SINUSITIS MARKET SHARE (%), BY REGION, 2020

FIGURE 15 AMERICAS: ACUTE SINUSITIS MARKET SHARE (%), BY REGION 2020

FIGURE 16 NORTH AMERICA: ACUTE SINUSITIS MARKET SHARE (%) BY COUNTRY 2020

FIGURE 17 EUROPE: ACUTE SINUSITIS MARKET SHARE (%), BY REGION, 2020

FIGURE 18 WESTERN EUROPE: ACUTE SINUSITIS MARKET SHARE (%), BY COUNTRY, 2020

FIGURE 19 ASIA PACIFIC: ACUTE SINUSITIS MARKET SHARE (%), BY COUNTRY, 2020

FIGURE 20 MIDDLE EAST & AFRICA: ACUTE SINUSITIS MARKET SHARE (%), BY COUNTRY, 2020

FIGURE 21 BENCHMARKING OF MAJOR COMPETITORS

FIGURE 22 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL ACUTE SINUSITIS MARKET

FIGURE 23 GLOBAL ACUTE SINUSITIS MARKET: COMPETITIVE LANDSCAPE

FIGURE 24 SALES 2020

FIGURE 25 RESEARCH & DEVELOPMENT EXPENDITURE, 2020

FIGURE 26 SANOFI: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 27 SANOFI: SWOT ANALYSIS

FIGURE 28 ABBOTT: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 29 ABBOTT: SWOT ANALYSIS

FIGURE 30 BAYER AG: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 31 BAYER AG: SWOT ANALYSIS

FIGURE 32 AUROBINDO PHARMA: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 33 AUROBINDO PHARMA: SWOT ANALYSIS

FIGURE 34 AUROBINDO PHARMA: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 35 BRISTOL MYERS SQUIBB: SWOT ANALYSIS

FIGURE 36 MERCK KGAA: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 37 MERCK KGAA: SWOT ANALYSIS

FIGURE 38 ASTRAZENECA: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 39 ASTRAZENECA: SWOT ANALYSIS

FIGURE 40 DR. REDDY’S LABORATORIES LTD: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 41 DR. REDDY’S LABORATORIES LTD: SWOT ANALYSIS

FIGURE 42 NOVARTIS AG: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 43 NOVARTIS AG: SWOT ANALYSIS

FIGURE 44 GLAXOSMITHKLINE PLC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 45 GLAXOSMITHKLINE PLC: SWOT ANALYSIS

List of Tables

LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS

TABLE 2 GLOBAL: ACUTE SINUSITIS MARKET, BY DIAGNOSIS & TREATMENT, 2018–2027 (USD MILLION)

TABLE 3 GLOBAL: ACUTE SINUSITIS MARKET, BY DIAGNOSIS, 2018–2027 (USD MILLION)

TABLE 4 GLOBAL: ACUTE SINUSITIS MARKET, BY TREATMENT, 2018–2027 (USD MILLION)

TABLE 5 GLOBAL: ACUTE SINUSITIS MARKET, FOR DIAGNOSIS, BY REGION, 2018–2027 (USD MILLION)

TABLE 6 GLOBAL: ACUTE SINUSITIS MARKET, FOR DIAGNOSIS, BY TYPE, 2018–2027 (USD MILLION)

TABLE 7 GLOBAL: ACUTE SINUSITIS MARKET, FOR NASAL ENDOSCOPY, BY REGION, 2018–2027 (USD MILLION)

TABLE 8 GLOBAL: ACUTE SINUSITIS MARKET, FOR IMAGING TEST, BY REGION, 2018–2027 (USD MILLION)

TABLE 9 GLOBAL: ACUTE SINUSITIS MARKET, FOR LABORATORY TEST, BY REGION, 2018–2027 (USD MILLION)

TABLE 10 GLOBAL: ACUTE SINUSITIS MARKET, FOR ALLERGY TESTING, BY REGION, 2018–2027 (USD MILLION)

TABLE 11 GLOBAL: ACUTE SINUSITIS MARKET, FOR TREATMENT, BY TYPE, 2018–2027 (USD MILLION)

TABLE 12 GLOBAL: ACUTE SINUSITIS MARKET, FOR TREATMENT, BY REGION, 2018–2027 (USD MILLION)

TABLE 13 GLOBAL: ACUTE SINUSITIS MARKET, FOR SALINE NASAL SPRAY, BY REGION, 2018–2027 (USD MILLION)

TABLE 14 GLOBAL: ACUTE SINUSITIS MARKET, FOR NASAL CORTICOSTEROIDS, BY REGION, 2018–2027 (USD MILLION)

TABLE 15 GLOBAL: ACUTE SINUSITIS MARKET, FOR DECONGESTANTS, BY REGION, 2018–2027 (USD MILLION)

TABLE 16 GLOBAL: ACUTE SINUSITIS MARKET, FOR OTC PAIN RELIEVERS, BY REGION, 2018–2027 (USD MILLION)

TABLE 17 GLOBAL: ACUTE SINUSITIS MARKET, FOR ALLERGY SHOTS, BY REGION, 2018–2027 (USD MILLION)

TABLE 18 GLOBAL: ACUTE SINUSITIS MARKET, FOR ANTIBIOTICS, BY REGION, 2018–2027 (USD MILLION)

TABLE 19 GLOBAL: ACUTE SINUSITIS MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 20 GLOBAL: ACUTE SINUSITIS MARKET, FOR HOSPITALS & CLINICS, BY REGION, 2018–2027 (USD MILLION)

TABLE 21 GLOBAL: ACUTE SINUSITIS MARKET, FOR RESEARCH CENTERS, BY REGION, 2018–2027 (USD MILLION)

TABLE 22 GLOBAL: ACUTE SINUSITIS MARKET, FOR OTHERS, BY REGION, 2018–2027 (USD MILLION)

TABLE 23 GLOBAL: ACUTE SINUSITIS MARKET, BY REGION, 2018–2027 (USD MILLION)

TABLE 24 AMERICAS: ACUTE SINUSITIS MARKET, BY REGION, 2018–2027 (USD MILLION)

TABLE 25 AMERICAS: ACUTE SINUSITIS MARKET, BY DIAGNOSIS & TREATMENT 2018–2027 (USD MILLION)

TABLE 26 AMERICAS: ACUTE SINUSITIS MARKET FOR DIAGNOSIS, BY TYPE, 2018–2027 (USD MILLION)

TABLE 27 AMERICAS: ACUTE SINUSITIS MARKET FOR TREATMENT, BY TYPE, 2018–2027 (USD MILLION)

TABLE 28 AMERICAS: ACUTE SINUSITIS MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 29 NORTH AMERICA: ACUTE SINUSITIS MARKET, BY COUNTRY, 2018–2027 (USD MILLION)

TABLE 30 NORTH AMERICA: ACUTE SINUSITIS MARKET, BY DIAGNOSIS & TREATMENT 2018–2027 (USD MILLION)

TABLE 31 NORTH AMERICA: ACUTE SINUSITIS MARKET FOR DIAGNOSIS, BY TYPE, 2018–2027 (USD MILLION)

TABLE 32 NORTH AMERICA: ACUTE SINUSITIS MARKET FOR TREATMENT, BY TYPE, 2018–2027 (USD MILLION)

TABLE 33 NORTH AMERICA: ACUTE SINUSITIS MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 34 US: ACUTE SINUSITIS MARKET, BY DIAGNOSIS & TREATMENT 2018–2027 (USD MILLION)

TABLE 35 US: ACUTE SINUSITIS MARKET FOR DIAGNOSIS, TYPE, 2018–2027 (USD MILLION)

TABLE 36 US: ACUTE SINUSITIS MARKET FOR TREATMENT, BY TYPE, 2018–2027 (USD MILLION)

TABLE 37 US: ACUTE SINUSITIS MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 38 CANADA: ACUTE SINUSITIS MARKET, BY DIAGNOSIS & TREATMENT 2018–2027 (USD MILLION)

TABLE 39 CANADA: ACUTE SINUSITIS MARKET FOR DIAGNOSIS, BY TYPE, 2018–2027 (USD MILLION)

TABLE 40 CANADA: ACUTE SINUSITIS MARKET FOR TREATMENT, BY TYPE, 2018–2027 (USD MILLION)

TABLE 41 CANADA: ACUTE SINUSITIS MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 42 SOUTH AMERICA: ACUTE SINUSITIS MARKET, BY DIAGNOSIS & TREATMENT 2018–2027 (USD MILLION)

TABLE 43 SOUTH AMERICA: ACUTE SINUSITIS MARKET FOR DIAGNOSIS, BY TYPE, 2018–2027 (USD MILLION)

TABLE 44 SOUTH AMERICA: ACUTE SINUSITIS MARKET FOR TREATMENT, BY TYPE, 2018–2027 (USD MILLION)

TABLE 45 SOUTH AMERICA: ACUTE SINUSITIS MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 46 EUROPE: ACUTE SINUSITIS MARKET, BY REGION, 2018–2027 (USD MILLION)

TABLE 47 EUROPE: ACUTE SINUSITIS MARKET, BY DIAGNOSIS & TREATMENT 2018–2027 (USD MILLION)

TABLE 48 EUROPE: ACUTE SINUSITIS MARKET FOR DIAGNOSIS, TYPE, 2018–2027 (USD MILLION)

TABLE 49 EUROPE: ACUTE SINUSITIS MARKET FOR TREATMENT, BY TYPE, 2018–2027 (USD MILLION)

TABLE 50 EUROPE: ACUTE SINUSITIS MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 51 WESTERN EUROPE: ACUTE SINUSITIS MARKET, BY COUNTRY, 2018–2027 (USD MILLION)

TABLE 52 WESTERN EUROPE: ACUTE SINUSITIS MARKET, BY DIAGNOSIS & TREATMENT 2018–2027 (USD MILLION)

TABLE 53 WESTERN EUROPE: ACUTE SINUSITIS MARKET FOR DIAGNOSIS, BY TYPE, 2018–2027 (USD MILLION)

TABLE 54 WESTERN EUROPE: ACUTE SINUSITIS MARKET FOR TREATMENT, BY TYPE, 2018–2027 (USD MILLION)

TABLE 55 WESTERN EUROPE: ACUTE SINUSITIS MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 56 GERMANY: ACUTE SINUSITIS MARKET, BY DIAGNOSIS & TREATMENT 2018–2027 (USD MILLION)

TABLE 57 GERMANY: ACUTE SINUSITIS MARKET FOR DIAGNOSIS, BY TYPE, 2018–2027 (USD MILLION)

TABLE 58 GERMANY: ACUTE SINUSITIS MARKET FOR TREATMENT, BY TYPE, 2018–2027 (USD MILLION)

TABLE 59 GERMANY: ACUTE SINUSITIS MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 60 FRANCE: ACUTE SINUSITIS MARKET, BY DIAGNOSIS & TREATMENT 2018–2027 (USD MILLION)

TABLE 61 FRANCE: ACUTE SINUSITIS MARKET FOR DIAGNOSIS, BY TYPE, 2018–2027 (USD MILLION)

TABLE 62 FRANCE: ACUTE SINUSITIS MARKET FOR TREATMENT, BY TYPE, 2018–2027 (USD MILLION)

TABLE 63 FRANCE: ACUTE SINUSITIS MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 64 UK: ACUTE SINUSITIS MARKET, BY DIAGNOSIS & TREATMENT 2018–2027 (USD MILLION)

TABLE 65 UK: ACUTE SINUSITIS MARKET FOR DIAGNOSIS, BY TYPE, 2018–2027 (USD MILLION)

TABLE 66 UK: ACUTE SINUSITIS MARKET FOR TREATMENT, BY TYPE, 2018–2027 (USD MILLION)

TABLE 67 UK: ACUTE SINUSITIS MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 68 ITALY: ACUTE SINUSITIS MARKET, BY DIAGNOSIS & TREATMENT 2018–2027 (USD MILLION)

TABLE 69 ITALY: ACUTE SINUSITIS MARKET FOR DIAGNOSIS, BY TYPE, 2018–2027 (USD MILLION)

TABLE 70 ITALY: ACUTE SINUSITIS MARKET FOR TREATMENT, BY TYPE, 2018–2027 (USD MILLION)

TABLE 71 ITALY: ACUTE SINUSITIS MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 72 SPAIN: ACUTE SINUSITIS MARKET, BY DIAGNOSIS & TREATMENT 2018–2027 (USD MILLION)

TABLE 73 SPAIN: ACUTE SINUSITIS MARKET FOR DIAGNOSIS, BY TYPE, 2018–2027 (USD MILLION)

TABLE 74 SPAIN: ACUTE SINUSITIS MARKET FOR TREATMENT, BY TYPE, 2018–2027 (USD MILLION)

TABLE 75 SPAIN: ACUTE SINUSITIS MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 76 REST OF WESTERN EUROPE: ACUTE SINUSITIS MARKET, BY DIAGNOSIS & TREATMENT 2018–2027 (USD MILLION)

TABLE 77 REST OF WESTERN EUROPE: ACUTE SINUSITIS MARKET FOR DIAGNOSIS, BY TYPE, 2018–2027 (USD MILLION)

TABLE 78 REST OF WESTERN EUROPE: ACUTE SINUSITIS MARKET FOR TREATMENT, BY TYPE, 2018–2027 (USD MILLION)

TABLE 79 REST OF WESTERN EUROPE: ACUTE SINUSITIS MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 80 EASTERN EUROPE: ACUTE SINUSITIS MARKET, BY DIAGNOSIS & TREATMENT 2018–2027 (USD MILLION)

TABLE 81 EASTERN EUROPE: ACUTE SINUSITIS MARKET FOR DIAGNOSIS, BY TYPE, 2018–2027 (USD MILLION)

TABLE 82 EASTERN EUROPE: ACUTE SINUSITIS MARKET FOR TREATMENT, BY TYPE, 2018–2027 (USD MILLION)

TABLE 83 EASTERN EUROPE: ACUTE SINUSITIS MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 84 ASIA PACIFIC: ACUTE SINUSITIS MARKET, BY COUNTRY, 2018–2027 (USD MILLION)

TABLE 85 ASIA-PACIFIC: ACUTE SINUSITIS MARKET, BY DIAGNOSIS & TREATMENT, 2018-2027 (USD MILLION)

TABLE 86 ASIA-PACIFIC: ACUTE SINUSITIS MARKET FOR DIAGNOSIS, BY TYPE, 2018-2027 (USD MILLION)

TABLE 87 ASIA-PACIFIC: ACUTE SINUSITIS MARKET FOR TREATMENT, BY TYPE, 2018-2027 (USD MILLION)

TABLE 88 ASIA-PACIFIC: ACUTE SINUSITIS MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 89 CHINA: ACUTE SINUSITIS MARKET, BY DIAGNOSIS & TREATMENT, 2018-2027 (USD MILLION)

TABLE 90 CHINA: ACUTE SINUSITIS MARKET FOR DIAGNOSIS, BY TYPE, 2018-2027 (USD MILLION)

TABLE 91 CHINA: ACUTE SINUSITIS MARKET FOR TREATMENT, BY TYPE, 2018-2027 (USD MILLION)

TABLE 92 CHINA: ACUTE SINUSITIS MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 93 INDIA: ACUTE SINUSITIS MARKET, BY DIAGNOSIS & TREATMENT, 2018-2027 (USD MILLION)

TABLE 94 INDIA: ACUTE SINUSITIS MARKET FOR DIAGNOSIS, BY TYPE, 2018-2027 (USD MILLION)

TABLE 95 INDIA: ACUTE SINUSITIS MARKET FOR TREATMENT, BY TYPE, 2018-2027 (USD MILLION)

TABLE 96 INDIA: ACUTE SINUSITIS MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 97 JAPAN: ACUTE SINUSITIS MARKET, BY DIAGNOSIS & TREATMENT, 2018-2027 (USD MILLION)

TABLE 98 JAPAN: ACUTE SINUSITIS MARKET FOR DIAGNOSIS, BY TYPE, 2018-2027 (USD MILLION)

TABLE 99 JAPAN: ACUTE SINUSITIS MARKET FOR TREATMENT, BY TYPE, 2018-2027 (USD MILLION)

TABLE 100 JAPAN: ACUTE SINUSITIS MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 101 REPUBLIC OF KOREA: ACUTE SINUSITIS MARKET, BY DIAGNOSIS & TREATMENT, 2018-2027 (USD MILLION)

TABLE 102 REPUBLIC OF KOREA: ACUTE SINUSITIS MARKET FOR DIAGNOSIS, BY TYPE, 2018-2027 (USD MILLION)

TABLE 103 REPUBLIC OF KOREA: ACUTE SINUSITIS MARKET FOR TREATMENT, BY TYPE, 2018-2027 (USD MILLION)

TABLE 104 REPUBLIC OF KOREA: ACUTE SINUSITIS MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 105 AUSTRALIA: ACUTE SINUSITIS MARKET, BY DIAGNOSIS & TREATMENT, 2018-2027 (USD MILLION)

TABLE 106 AUSTRALIA: ACUTE SINUSITIS MARKET FOR DIAGNOSIS, BY TYPE, 2018-2027 (USD MILLION)

TABLE 107 AUSTRALIA: ACUTE SINUSITIS MARKET FOR TREATMENT, BY TYPE, 2018-2027 (USD MILLION)

TABLE 108 AUSTRALIA: ACUTE SINUSITIS MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 109 REST OF ASIA PACIFIC: ACUTE SINUSITIS MARKET, BY DIAGNOSIS & TREATMENT, 2018-2027 (USD MILLION)

TABLE 110 REST OF ASIA PACIFIC: ACUTE SINUSITIS MARKET FOR DIAGNOSIS, BY TYPE, 2018-2027 (USD MILLION)

TABLE 111 REST OF ASIA PACIFIC: ACUTE SINUSITIS MARKET FOR TREATMENT, BY TYPE, 2018-2027 (USD MILLION)

TABLE 112 REST OF ASIA PACIFIC: ACUTE SINUSITIS MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 113 MIDDLE EAST & AFRICA: ACUTE SINUSITIS MARKET, BY COUNTRY, 2018–2027 (USD MILLION)

TABLE 114 MIDDLE EAST AND AFRICA: ACUTE SINUSITIS MARKET, BY DIAGNOSIS & TREATMENT, 2018-2027 (USD MILLION)

TABLE 115 MIDDLE EAST AND AFRICA: ACUTE SINUSITIS MARKET FOR DIAGNOSIS, BY TYPE, 2018-2027 (USD MILLION)

TABLE 116 MIDDLE EAST AND AFRICA: ACUTE SINUSITIS MARKET FOR TREATMENT, BY TYPE, 2018-2027 (USD MILLION)

TABLE 117 MIDDLE EAST AND AFRICA: ACUTE SINUSITIS MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 118 SAUDI ARABIA: ACUTE SINUSITIS MARKET, BY DIAGNOSIS & TREATMENT, 2018-2027 (USD MILLION)

TABLE 119 SAUDI ARABIA: ACUTE SINUSITIS MARKET FOR DIAGNOSIS, BY TYPE, 2018-2027 (USD MILLION)

TABLE 120 SAUDI ARABIA: ACUTE SINUSITIS MARKET FOR TREATMENT, BY TYPE, 2018-2027 (USD MILLION)

TABLE 121 SAUDI ARABIA: ACUTE SINUSITIS MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 122 UNITED ARAB EMIRATES: ACUTE SINUSITIS MARKET, BY DIAGNOSIS & TREATMENT, 2018-2027 (USD MILLION)

TABLE 123 UNITED ARAB EMIRATES: ACUTE SINUSITIS MARKET FOR DIAGNOSIS, BY TYPE, 2018-2027 (USD MILLION)

TABLE 124 UNITED ARAB EMIRATES: ACUTE SINUSITIS MARKET FOR TREATMENT, BY TYPE, 2018-2027 (USD MILLION)

TABLE 125 UNITED ARAB EMIRATES: ACUTE SINUSITIS MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 126 OMAN: ACUTE SINUSITIS MARKET, BY DIAGNOSIS & TREATMENT, 2018-2027 (USD MILLION)

TABLE 127 OMAN: ACUTE SINUSITIS MARKET FOR DIAGNOSIS, BY TYPE, 2018-2027 (USD MILLION)

TABLE 128 OMAN: ACUTE SINUSITIS MARKET FOR TREATMENT, BY TYPE, 2018-2027 (USD MILLION)

TABLE 129 OMAN: ACUTE SINUSITIS MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 130 KUWAIT: ACUTE SINUSITIS MARKET, BY DIAGNOSIS & TREATMENT, 2018-2027 (USD MILLION)

TABLE 131 KUWAIT: ACUTE SINUSITIS MARKET FOR DIAGNOSIS, BY TYPE, 2018-2027 (USD MILLION)

TABLE 132 KUWAIT: ACUTE SINUSITIS MARKET FOR TREATMENT, BY TYPE, 2018-2027 (USD MILLION)

TABLE 133 KUWAIT: ACUTE SINUSITIS MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 134 QATAR: ACUTE SINUSITIS MARKET, BY DIAGNOSIS & TREATMENT, 2018-2027 (USD MILLION)

TABLE 135 QATAR: ACUTE SINUSITIS MARKET FOR DIAGNOSIS, BY TYPE, 2018-2027 (USD MILLION)

TABLE 136 QATAR: ACUTE SINUSITIS MARKET FOR TREATMENT, BY TYPE, 2018-2027 (USD MILLION)

TABLE 137 QATAR: ACUTE SINUSITIS MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 138 REST OF THE MIDDLE EAST & AFRICA: ACUTE SINUSITIS MARKET, BY DIAGNOSIS & TREATMENT, 2018-2027 (USD MILLION)

TABLE 139 REST OF THE MIDDLE EAST & AFRICA: ACUTE SINUSITIS MARKET FOR DIAGNOSIS, BY TYPE, 2018-2027 (USD MILLION)

TABLE 140 REST OF THE MIDDLE EAST & AFRICA: ACUTE SINUSITIS MARKET FOR TREATMENT, BY TYPE, 2018-2027 (USD MILLION)

TABLE 141 REST OF THE MIDDLE EAST & AFRICA: ACUTE SINUSITIS MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 142 MAJOR PLAYERS IN THE GLOBAL ACUTE SINUSITIS MARKET

TABLE 143 MOST ACTIVE PLAYER IN THE GLOBAL ACUTE SINUSITIS MARKET

TABLE 144 PRODUCT LAUNCH/PRODUCT APPROVALS

TABLE 145 MERGERS & ACQUISITIONS

TABLE 146 SANOFI: PRODUCTS/SERVICES OFFERED

TABLE 147 ABBOTT: PRODUCTS /SERVICES OFFERED

TABLE 148 BAYER AG: PRODUCTS/SERVICES OFFERED

TABLE 149 AUROBINDO PHARMA: PRODUCTS/SERVICES OFFERED

TABLE 150 BRISTOL MYERS SQUIBB: PRODUCTS/SERVICES OFFERED

TABLE 151 MERCK KGAA: PRODUCTS/SERVICES OFFERED

TABLE 152 ASTRAZENECA: PRODUCTS/SERVICES OFFERED

TABLE 153 DR. REDDY?S LABORATORIES LTD: PRODUCTS/SERVICES OFFERED

TABLE 154 DR. REDDY?S LABORATORIES LTD: KEY DEVELOPMENTS

TABLE 155 NOVARTIS AG: PRODUCTS OFFERED

TABLE 156 NOVARTIS AG: KEY DEVELOPMENTS

TABLE 157 GLAXOSMITH KLINE PLC: PRODUCTS/SERVICES OFFERED